ALB and cancer: Recently, several biomarkers and hematological indices representative of systemic inflammatory responses, including the neutrophil–lymphocyte ratio (NLR), the platelet–lymphocyte ratio (PLR), and the combination of the C-reactive protein (CRP) and albumin known as the Glasgow prognostic score (GPS) were introduced as prognostic factors in various cancers.